These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4898877)

  • 1. [Anti-influenzal thermolabile inhibiting factors of normal and immune serums].
    Csaky N
    Stud Cercet Inframicrobiol; 1969; 20(1):53-62. PubMed ID: 4898877
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the biochemistry of thermolabile factors of normal sera activating immune anti-influenza sera].
    POLIAK RIa; IABROV AA
    Vopr Virusol; 1961; 6():678-84. PubMed ID: 14487533
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production of specific anti-influenzal sera].
    ROVNOVA ZI
    Vopr Virusol; 1959; 4():465-70. PubMed ID: 14439666
    [No Abstract]   [Full Text] [Related]  

  • 4. [Distribution of anti-influenzal hemagglution-inhibiting antibodies against types (A2 and B) of circulating influenza virus in the population of the city of Bucharest in the period 1962-1964].
    Solomon I; Duvan X; Scheau A; Niţulescu C
    Stud Cercet Inframicrobiol; 1965; 16(4):349-54. PubMed ID: 5864435
    [No Abstract]   [Full Text] [Related]  

  • 5. [Investigations of the average level of anti-influenzal antibodies by performance of the HAI test with test-mixtures of sera].
    Solomon I; Grigoriu T; Scheau A; Duvan X; Niţulescu C
    Stud Cercet Inframicrobiol; 1966; 17(2):129-32. PubMed ID: 5940422
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
    Beebe DP; Schreiber RD; Cooper NR
    J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody content of immune sera absorbed with influenza virus, as determined by different serological tests.
    TAKATSY G; HAMAR M
    Acta Microbiol Acad Sci Hung; 1956; 3(3):299-306. PubMed ID: 13326293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the effectiveness of living anti-influenzal vaccine in the interepidemic period].
    Ginzburg LIa; Rubinshteĭn GG; Zhuk AS; Shulichenko AI; Ukazov IV; Dromashko AS
    Vrach Delo; 1966 Sep; 9():112-4. PubMed ID: 6001230
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemistry of the heat labile factor of normal sera activating the effect of influenza immune sera.
    POLYAK RY; YABROV AA
    Probl Virol; 1961; 6():736-43. PubMed ID: 14038438
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the study of the relation between serum properdin and pyrogenic substances from purified antitoxic serums].
    Toma E; Szégli G; Gartner M; Negut M
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):967-72. PubMed ID: 5836099
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza prevention 2003-2004.
    Med Lett Drugs Ther; 2003 Sep; 45(1166):78-80. PubMed ID: 14506470
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood group affiliation of positive influenza A2 sera].
    Heise R; Stelzner A; Urbach H; Talaska W
    Z Gesamte Hyg; 1976 Mar; 22(3):229-31. PubMed ID: 969733
    [No Abstract]   [Full Text] [Related]  

  • 13. [Laboratory tests with 2 anti-influenzal preparations--flumidine and injectio bupleuri (Chai-hu)].
    SMEJKAL F
    Cas Lek Cesk; 1962 Nov; 101():1348-53. PubMed ID: 13989330
    [No Abstract]   [Full Text] [Related]  

  • 14. [On a method for the study of the effectiveness of anti-influenza serum].
    RAIKHSHTAT GN
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Sep; 33():60-4. PubMed ID: 14489933
    [No Abstract]   [Full Text] [Related]  

  • 15. Formation of antibodies of different classes in influenzal infections.
    Dobrovolskaya NG
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(2):148-55. PubMed ID: 5104224
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influenza vaccination: NOW!].
    Heinzl S
    Med Monatsschr Pharm; 2006 Nov; 29(11):389. PubMed ID: 17131684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neutralizing and inhibiting activity of hemagglutination of serum antibodies after natural infection and after vaccination with influenza virus A/USSR/90/77 (H1N1) strain].
    Profeta ML; Nardi G
    Boll Ist Sieroter Milan; 1983 May; 62(2):130-6. PubMed ID: 6626319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune-adherence activity of normal serum.
    TURK JL
    Br J Exp Pathol; 1959 Apr; 40(2):97-106. PubMed ID: 13638490
    [No Abstract]   [Full Text] [Related]  

  • 20. Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
    Eichelberger MC; Prince GA; Ottolini MG
    Virology; 2004 May; 322(2):300-7. PubMed ID: 15110527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.